Champions Oncology, Inc. (CSBR) Starts Presentation at Annual Marcum MicroCap Conference

Champions Oncology, Inc. (OTCQB: CSBR) develops advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune-deficient mice to create TumorGrafts that preserve the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. For more information, visit the company’s website at www.championsoncology.com